Search Within

David H Ilson

  1. "Computational Oncology Service"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (13)
Groups
  1. Computational Oncology Service (30)
  2. Department of Medicine (30)
  3. Epidemiology and Biostatistics (30)
  4. GSK Faculty (30)
  5. Gastrointestinal Oncology Service (30)
  6. Hematologic Malignancies, Division of (30)

More Groups

People
  1. Geoffrey Ku (30)
  2. Nikolaus Schultz (30)
  3. Yelena Janjigian (30)
  4. David Solit (21)
  5. Jaclyn Hechtman (19)
  6. David Kelsen (18)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Clinical Cancer Research (4)
  3. Annals of Oncology (2)
  4. Cancer Discovery (2)
  5. JAMA Network Open (2)
  6. Annals of Surgery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (4)
  4. American Medical Association (2)
  5. Elsevier Science, Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Survival of locally advanced MSI-high gastric cancer patients treated with perioperative chemotherapy: A retrospective cohort study
    Journal Article

    Vos, E. L.; Maron, S. B.; Krell, R. W.; Nakauchi, M.; Fiasconaro, M.; Capanu, M.; Walch, H. S.; Chatila, W. K.; Schultz, N.; Ilson, D. H.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Differences in genomic profiles of gastric adenocarcinoma in the US and Japan
    Meeting Abstract

    Nakauchi, M.; Court, C.; Walsh, H. S.; Chatila, W. K.; Shimada, S.; Vardhana, S.; Tang, L. H.; Coit, D. G.; Janjigian, Y. Y.; Maron, S. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes and molecular features of brain metastasis in gastroesophageal adenocarcinoma
    Journal Article

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Feder, L.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features
    Meeting Abstract

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save